We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Loss of Brain White Matter Increases Stroke Risk

By Biotechdaily staff writers
Posted on 31 Jul 2003
Researchers have established that leukoaraiosis, changes in the brain's white matter that usually occur in the elderly, increases the risk of multiple strokes.

Investigators studied 685 patients aged 34 to 84 years with carotid artery disease who participated in the 2,885-patient North American Symptomatic Carotid Endarterectomy Trial (NASCET) and who had a follow-up computed tomography (CT) scan taken three years or more from entry in the study.

Of the 685 patients in the study, 596 had no leukoaraiosis and 89 had limited white matter. More...
During an average follow-up of 6.1 years, 18% of the 596 patients initially free of leukoaraiosis developed some loss of white matter and 3% had widespread loss. The average age of patients who developed leukoaraiosis was 66.8 years.

The group of patients who developed leukoaraiosis showed a higher tendency to experience at least one stroke: 36% versus 23.5% for the group without leukoaraiosis. After taking gender, age, smoking history, and diseases such as hypertension and diabetes mellitus into consideration, results showed that the patients who developed leukoaraiosis were 1.5 times more likely to have a stroke. The findings were published July 17, 2003, in the online edition of Stroke.

"Patients who developed leukoaraiosis were more likely to have multiple strokes, which generally lead to increased disability, both physically and mentally,” said first author Dr. Jonathan Y. Streifler, director of the neurology unit at the Rabin Medical Center (Petach Tikva, Israel). "These small strokes can be devastating when they hit strategic connections.”

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Gold Member
Aspiration System
VACUSAFE
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.